A founder effect identified in South Indian patients with beta-sarcoglycanopathy

Beta sarcoglycanopathy is one of the four forms of limb-girdle myopathy associated with sarcoglycan deficiency. Indian clinicians have just identified an outbreak of this disease in their country:

  • 14 patients from 13 unrelated families in southern India (the states of Karnataka, Tamil Nadu and Andra Pradesh) were diagnosed with limb-girdle muscular dystrophy with beta-sarcoglycan deficiency,
  • all carried the same c.544T>G mutation (p.Thr182Pro),
  • additional haplotyping studies in the 14 patients and 150 healthy subjects, using ten polymorphic markers of the corresponding chromosomal region, confirmed the existence of a highly probable founder effect in the region.

These results could have positive repercussions at a time when gene therapy trials are being set up for this type of limb-girdle muscular dystrophy.

 

Identification of a shared, common haplotype segregating with an SGCB c.544 T > G mutation in Indian patients affected with sarcoglycanopathy. Sanga S, Chakraborty S, Bardhan M et al. Sci Rep. 2023 Sep 12;13(1):15095.